Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Melanoma of the Skin (All Stages^), 2019

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate ascending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Recent Trend
Recent 5-Year Trend in Incidence Rates
(95% Confidence Interval)
 sort by trend descending
US (SEER+NPCR) 1 22.7 (22.5, 22.8) N/A 88,059 stable stable trend -0.4 (-1.9, 1.0)
Utah 7 43.4 (41.0, 45.9) 1 (1, 1) 1,250 stable stable trend 0.4 (-1.5, 2.3)
Minnesota 2 35.5 (34.0, 37.0) 2 (2, 4) 2,343 rising rising trend 3.5 (2.6, 4.4)
Vermont 2 32.9 (28.8, 37.5) 3 (2, 17) 266 stable stable trend -3.5 (-10.9, 4.6)
Iowa 7 32.0 (30.1, 34.0) 4 (2, 9) 1,197 rising rising trend 3.3 (3.1, 3.6)
New Hampshire 2 31.0 (28.4, 33.8) 5 (2, 15) 584 stable stable trend 0.5 (-0.4, 1.4)
Montana 2 30.5 (27.5, 33.8) 6 (2, 19) 410 rising rising trend 3.7 (3.1, 4.3)
Idaho 7 29.9 (27.5, 32.5) 7 (3, 18) 610 rising rising trend 1.8 (1.2, 2.4)
Nebraska 2 29.9 (27.6, 32.4) 8 (3, 18) 645 stable stable trend 3.5 (-0.1, 7.2)
Kansas 2 29.0 (27.1, 31.0) 9 (4, 18) 964 rising rising trend 2.5 (2.0, 3.0)
Kentucky 7 27.8 (26.4, 29.3) 10 (6, 20) 1,489 rising rising trend 2.0 (1.7, 2.4)
Washington 4 27.7 (26.5, 28.8) 11 (7, 19) 2,428 rising rising trend 0.5 (0.1, 0.9)
North Carolina 2 27.5 (26.6, 28.5) 12 (8, 19) 3,442 rising rising trend 1.2 (0.2, 2.3)
Delaware 2 27.3 (24.5, 30.4) 13 (4, 27) 362 falling falling trend -1.5 (-2.1, -0.8)
Arkansas 2 27.1 (25.4, 29.0) 14 (7, 22) 978 rising rising trend 5.1 (4.5, 5.6)
Arizona 2 26.8 (25.7, 27.9) 15 (9, 21) 2,461 stable stable trend 2.9 (-4.8, 11.3)
Ohio 2 26.7 (25.8, 27.6) 16 (10, 21) 3,825 rising rising trend 2.6 (1.9, 3.3)
Maryland 2 26.7 (25.5, 28.0) 17 (9, 22) 1,933 rising rising trend 1.5 (0.9, 2.1)
Wyoming 2 26.5 (22.7, 30.9) 18 (3, 34) 184 rising rising trend 1.8 (0.5, 3.2)
Hawaii 7 26.5 (24.1, 29.1) 19 (6, 27) 477 rising rising trend 2.5 (1.9, 3.1)
Georgia 7 25.4 (24.4, 26.3) 20 (15, 25) 2,964 stable stable trend -2.0 (-3.9, 0.0)
Oregon 2 25.1 (23.7, 26.5) 21 (14, 27) 1,324 falling falling trend -4.1 (-7.8, -0.2)
Maine 2 24.9 (22.5, 27.4) 22 (9, 32) 474 rising rising trend 1.4 (0.8, 2.1)
Florida 2 24.5 (23.9, 25.1) 23 (19, 26) 7,503 stable stable trend -0.8 (-6.0, 4.6)
Illinois 7 24.1 (23.3, 24.9) 24 (19, 28) 3,594 rising rising trend 4.5 (3.0, 6.1)
Wisconsin 2 23.2 (22.0, 24.4) 25 (21, 32) 1,640 stable stable trend -3.1 (-6.6, 0.5)
South Dakota 2 23.2 (20.3, 26.4) 26 (11, 41) 249 rising rising trend 4.0 (2.8, 5.2)
California 7 23.1 (22.6, 23.6) 27 (23, 30) 10,303 rising rising trend 1.2 (1.0, 1.5)
Tennessee 2 22.4 (21.3, 23.4) 28 (23, 34) 1,838 stable stable trend -0.1 (-1.2, 1.0)
Virginia 2 21.9 (20.9, 22.8) 29 (25, 35) 2,226 rising rising trend 2.1 (0.5, 3.8)
West Virginia 2 21.8 (19.9, 23.9) 30 (21, 41) 518 rising rising trend 1.6 (1.0, 2.2)
New Jersey 7 21.6 (20.7, 22.5) 31 (26, 36) 2,388 stable stable trend 0.3 (-0.1, 0.8)
Rhode Island 2 21.6 (19.1, 24.3) 32 (20, 44) 292 stable stable trend -0.2 (-1.0, 0.7)
Colorado 2 21.2 (20.1, 22.4) 33 (26, 39) 1,351 stable stable trend 0.2 (-0.3, 0.7)
North Dakota 2 21.1 (18.0, 24.6) 34 (18, 46) 177 stable stable trend -0.2 (-2.1, 1.9)
South Carolina 2 20.1 (19.0, 21.2) 35 (30, 43) 1,317 stable stable trend -3.4 (-8.6, 2.0)
Pennsylvania 2 20.1 (19.4, 20.8) 36 (32, 41) 3,321 falling falling trend -5.0 (-6.9, -3.1)
Oklahoma 2 20.0 (18.7, 21.4) 37 (29, 43) 907 stable stable trend -3.8 (-8.6, 1.3)
Alabama 2 19.7 (18.6, 20.9) 38 (31, 44) 1,182 stable stable trend 0.4 (-1.3, 2.1)
Mississippi 2 19.6 (18.1, 21.2) 39 (29, 45) 667
*
*
Michigan 2 19.3 (18.5, 20.1) 40 (33, 44) 2,368 rising rising trend 0.7 (0.2, 1.2)
Connecticut 7 19.0 (17.8, 20.4) 41 (33, 46) 900 falling falling trend -1.9 (-2.6, -1.3)
New York 7 18.5 (17.9, 19.0) 42 (38, 46) 4,444 stable stable trend 0.6 (-0.1, 1.3)
Louisiana 7 18.3 (17.1, 19.5) 43 (36, 47) 968 rising rising trend 3.1 (2.6, 3.7)
Indiana 2 18.0 (17.0, 19.0) 44 (39, 47) 1,414 falling falling trend -5.1 (-9.5, -0.4)
Missouri 2 17.5 (16.5, 18.5) 45 (40, 47) 1,304 stable stable trend -3.0 (-8.2, 2.5)
New Mexico 7 16.7 (15.1, 18.4) 46 (40, 49) 443 stable stable trend -0.8 (-1.7, 0.2)
Texas 7 15.8 (15.3, 16.3) 47 (46, 49) 4,658 stable stable trend 4.1 (-0.6, 8.9)
Alaska 2 15.3 (12.5, 18.6) 48 (37, 49) 111 stable stable trend 1.5 (0.0, 3.1)
Massachusetts 7 15.1 (14.3, 16.0) 49 (46, 49) 1,297 stable stable trend -10.4 (-20.0, 0.4)
District of Columbia 2 9.0 (6.8, 11.5) 50 (50, 50) 63 stable stable trend 0.9 (-0.3, 2.1)
Puerto Rico 2 4.4 (3.8, 5.1) N/A 184 stable stable trend 4.8 (-7.7, 19.0)
Nevada 2
data not available
N/A
data not available
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 02/08/2023 11:06 am.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
‡ Incidence data come from different sources. Due to different years of data availability, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. Please refer to the source for each area for additional information.

Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).
Data not available for this combination of data selections.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2019) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2021 submission.
2 Source: National Program of Cancer Registries SEER*Stat Database (2001-2019) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2021 submission).
4 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2019) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2021 submission.
7 Source: SEER November 2021 submission.
8 Source: Incidence data provided by the SEER Program. AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Population counts for denominators are based on Census populations as modifed by NCI. The US Population Data File is used with SEER November 2021 data.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top